Agios Pharmac(AGIO.US)

Event Tracking

Dec26

Agios Pharmaceuticals' stock price fell by 5.3%

18:20

Andrew Berens Maintains Buy Rating for Agios Pharmaceuticals with a Target Price of $40

11:32

Goldman Sachs Raises Agios Pharmaceuticals Target Price and Analyzes Core Drug Prospects

11:27

TD Cowen Analyst Maintains Buy Rating on Agios Pharma

03:22

Dec24

Agios Pharmaceuticals Announces FDA Approval of AQVESME for Thalassemia

00:45

Dec8

Agios Pharmaceuticals' Pyrukynd Expected to Receive FDA Approval

17:42

Schedules & Filings

Schedules

Filings

Oct30

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 12.88 M, Net Income -103.43 M, EPS -1.7799

Jul31

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 12.46 M, Net Income -112.02 M, EPS -1.9336

May1

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 8.726 M, Net Income -89.29 M, EPS -1.5539

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change